Option Care Health, Inc. (NASDAQ:OPCH) to Post Q1 2025 Earnings of $0.30 Per Share, Barrington Research Forecasts

Option Care Health, Inc. (NASDAQ:OPCH) – Equities researchers at Barrington Research upped their Q1 2025 earnings per share estimates for shares of Option Care Health in a research note issued on Wednesday, April 24th. Barrington Research analyst M. Petusky now expects that the company will earn $0.30 per share for the quarter, up from their prior forecast of $0.26. Barrington Research has a “Outperform” rating and a $38.00 price objective on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.13 per share. Barrington Research also issued estimates for Option Care Health’s Q4 2025 earnings at $0.37 EPS and FY2026 earnings at $1.55 EPS.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period in the prior year, the firm posted $0.21 EPS. The company’s revenue for the quarter was up 12.8% on a year-over-year basis.

Separately, Jefferies Financial Group increased their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Performance

OPCH opened at $29.93 on Thursday. The firm has a market cap of $5.20 billion, a P/E ratio of 19.69, a price-to-earnings-growth ratio of 1.74 and a beta of 1.22. Option Care Health has a 52-week low of $24.23 and a 52-week high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The business’s fifty day moving average is $32.13 and its 200-day moving average is $31.52.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction dated Monday, February 26th. The shares were bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by insiders.

Institutional Trading of Option Care Health

Large investors have recently bought and sold shares of the business. Mutual of America Capital Management LLC boosted its stake in Option Care Health by 63.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock valued at $6,424,000 after buying an additional 73,938 shares in the last quarter. Wellington Management Group LLP raised its position in Option Care Health by 15.9% in the third quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company’s stock valued at $93,698,000 after purchasing an additional 397,627 shares during the last quarter. HealthInvest Partners AB bought a new position in Option Care Health in the fourth quarter valued at about $1,254,000. Ontario Teachers Pension Plan Board bought a new position in Option Care Health in the third quarter valued at about $546,000. Finally, Van ECK Associates Corp raised its position in Option Care Health by 244.2% in the third quarter. Van ECK Associates Corp now owns 34,291 shares of the company’s stock valued at $1,109,000 after purchasing an additional 24,328 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.